Abacavir and Lamivudine
- Product NDC
- 70518-0715
- 11-digit product format
- 705180715
- Labeler code
- 70518
- Product ID
- 70518-0715_8bc81904-0278-a108-e053-2995a90ad60f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Abacavir and Lamivudine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA204990
- Marketing category
- ANDA
- Marketing start
- 2017-08-28
- Marketing end
- 0000-00-00
- Substance
- ABACAVIR SULFATE; LAMIVUDINE
- Active strength
- 600 mg/1; mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record